Ledger.Open graph →
SEC Form D · filed September 20, 2018

Silverback Therapeutics, Inc

Offering
$20.0M
Sold
$12.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Saqib A. Islam · Seattle, WADirectorPeter A. Thompson · Vancouver, British Columbia, CanadaExec · DirectorRobert A. Hershberg · Seattle, WADirectorSaqib A. Islam · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗